Please use this identifier to cite or link to this item: https://hdl.handle.net/10923/25169
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNatan Pereira Gosmann-
dc.contributor.authorMariana de Abreu Costa-
dc.contributor.authorMariana de Barros Jaeger-
dc.contributor.authorLuis Souza Motta-
dc.contributor.authorJúlia Frozi-
dc.contributor.authorLucas Spanemberg-
dc.contributor.authorGisele Gus Manfro-
dc.contributor.authorPim Cuijpers-
dc.contributor.authorDaniel Samuel Pine-
dc.contributor.authorSALUM, GIOVANNI ABRAHÃO-
dc.date.accessioned2023-06-05T18:30:49Z-
dc.date.available2023-06-05T18:30:49Z-
dc.date.issued2021-
dc.identifier.issn1549-1676-
dc.identifier.urihttps://hdl.handle.net/10923/25169-
dc.language.isoen-
dc.relation.ispartofPLOS MEDICINE-
dc.rightsopenAccess-
dc.titleSelective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis-
dc.typeArticle-
dc.date.updated2023-06-05T18:30:48Z-
dc.identifier.doiDOI:10.1371/journal.pmed.1003664-
dc.jtitlePLOS MEDICINE-
dc.volume18-
dc.issue6-
dc.spagee1003664-
Appears in Collections:Artigo de Periódico



All Items in PUCRS Repository are protected by copyright, with all rights reserved, and are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Read more.